Skip to Main Content

Paper Details

Using genomics to better define high-risk MGUS/SMM patients.
Oncotarget
2
2018
Author NameAffiliation
J Lynn FinkAdelaide Medical School, The University of Adelaide, South Australian Health and Medical Research Institute (SAHMRI)
  • 1 - 1

Datasets

Release 1.2